Precision Optics (POCI) Planet MicroCap Las Vegas 2026 summary
Event summary combining transcript, slides, and related documents.
Planet MicroCap Las Vegas 2026 summary
17 Jun, 2026Business model and technology focus
Specializes in optics for medical devices, with growing presence in defense and aerospace.
Maintains IP ownership while developing custom solutions for clients, charging on a time and materials basis.
Vertically and horizontally integrated, enabling design-to-manufacture and full imaging system delivery.
Modular platform approach reduces time to market, cost, and regulatory risk for new programs.
Acquisitions have expanded capabilities and supply chain reach.
Key technologies and applications
Micro-optics enable some of the smallest optical systems, critical for minimally invasive medical procedures.
3D imaging and ultra-high resolution systems originated from robotic surgery applications, now expanding to AR/VR and fluorescence imaging.
Digital imaging leverages CMOS sensors for single-use endoscopes, opening new market segments.
Technologies also reduce size and weight for defense and aerospace, supporting satellite and directed energy weapon applications.
Recent growth and production ramp
Two major programs transitioned from development to production, driving significant revenue growth.
Single-use cystoscopy program scaled from 1,000 to nearly 50,000 units annually, now at $8M run rate.
Satellite optomechanical assembly program at $12M run rate, with long-term recurring demand due to satellite replacement cycles.
Several other programs nearing production, expected to contribute $1–3M each annually.
Latest events from Precision Optics
- Accelerated revenue growth driven by new production programs and robust technology pipeline.POCI
Lytham Partners Spring 2026 Investor Conference28 May 2026 - Strong revenue growth, major new orders, and expanding product pipeline drive future prospects.POCI
Corporate presentation24 May 2026 - Record Q3 revenue, margin gains, and a $10M+ offering drove raised FY2026 guidance.POCI
Q3 202614 May 2026 - Strong revenue growth and major orders fuel expansion in medical and defense optics.POCI
Investor presentation16 Apr 2026 - Record revenue growth offset by margin compression and liquidity risks.POCI
Q2 202617 Feb 2026 - Shareholders will vote on director elections, executive pay, and auditor ratification at the 2025 meeting.POCI
Proxy Filing3 Feb 2026 - Votes will be cast on director elections, executive pay, and auditor ratification at the 2026 meeting.POCI
Proxy Filing2 Feb 2026 - Annual meeting to elect directors, approve executive pay, and ratify auditor, with strong governance.POCI
Proxy Filing2 Feb 2026 - Record engineering revenue and new orders support double-digit growth expectations for FY2025.POCI
Q4 202420 Jan 2026